Is There a Correlation Between Androgens and Sexual Desire in Women?

Journal of Sexual Medicine

Volumn 12, Issue 2, 2015, Pages 358-373

  Wåhlin Jacobsen, Sarah ^a   Pedersen, Anette Tønnes ^b   Kristensen, Ellids ^a,c   Læssøe, Nanna Cassandra ^a   Lundqvist, Marika ^d   Cohen, Arieh S ^d   Hougaard, David M ^d   Giraldi, Annamaria ^a  

^a Psychiatric Center Copenhagen   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

17b Hydroxysteroid Dehydrogenase; Androgen; Androgen Metabolites; Androstenedione; Androsterone Glucuronide; DHEAS; FSFI; Sexual Desire; Testosterone; Woman

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ANDROSTERONE; GLUCURONIDE; PRASTERONE SULFATE; TESTOSTERONE; ANDROSTANE DERIVATIVE; ANDROSTERONE GLUCURONIDE;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; FEMALE; FEMALE SEXUAL FUNCTION INDEX; GROUPS BY AGE; HORMONAL CONTRACEPTION; HUMAN; LIBIDO; MASS SPECTROMETRY; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; TESTOSTERONE BLOOD LEVEL; YOUNG ADULT; AGE; ANALOGS AND DERIVATIVES; BLOOD; MIDDLE AGED; MOLECULAR GENETICS; PHYSIOLOGY; SOCIOECONOMICS; WOMEN'S HEALTH;

ADULT; AGE FACTORS; AGED; ANDROGENS; ANDROSTENEDIONE; ANDROSTENOLS; ANDROSTERONE; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; LIBIDO; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SOCIOECONOMIC FACTORS; TESTOSTERONE; WOMEN'S HEALTH;

EID: 84922667052     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12774     Document Type: Article

References (41)

1. Brotto LA, Petkau AJ, Labrie F, Basson R. Predictors of sexual desire disorders in women. J Sex Med 2011;8:742-753.
2. Eplov L, Giraldi A, Davidsen M, Garde K, Kamper-Jørgensen F. Sexual desire in a nationally representative Danish population. J Sex Med 2007;4:47-56.
3. Nicolosi A, Laumann EO, Glasser DB, Moreira ED Jr, Paik A, Gingell C. Sexual behavior and sexual dysfunctions after age 40: The global study of sexual attitudes and behaviors. Urology 2004;64:991-997.
4. Rosen RC, Shifren JL, Monz BU, Odom DM, Russo PA, Johannes CB. Correlates of sexually related personal distress in women with low sexual desire. J Sex Med 2009;6:1549-1560.
5. Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, Goldstein I, Guay A, Leiblum S, Lobo R, Notelovitz M, Rosen R, Sarrel P, Sherwin B, Simon J, Simpson E, Shifren J, Spark R, Traish A, Princeton . Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002;77:660-665.
6. Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, Rodenberg CA, Wekselman K, Casson P. Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gynecol 2005;105(5 Pt 1):944-952.
7. Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90:5226-5233.
8. Davis SR, van der Mooren MJ, van Lunsen RHW, Lopes P, Ribot C, Ribot J, Rees M, Moufarege A, Rodenberg C, Buch A, Purdie DW. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial. Menopause 2006;13:387-396.
9. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-688.
10. Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial. Arch Intern Med 2005;165:1582-1589.
11. Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C, Bearnson P, Kakos N, O'Neill S, Levine S, Wekselman K, Buch A, Rodenberg C, Kroll R. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study. Menopause 2006;13:770-779.
12. Nathorst-Böös J, Flöter A, Jarkander-Rolff M, Carlström K, Schoultz B. Treatment with percutaneous testosterone gel in postmenopausal women with decreased libido-Effects on sexuality and psychological general well-being. Maturitas 2006;53:11-18.
13. Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg C, Pack S, Koch H, Moufarege A, Studd J. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008;359:2005-2017.
14. Panay N, Al-Azzawi F, Bouchard C, Davis SR, Eden J, Lodhi I, Rees M, Rodenberg CA, Rymer J, Schwenkhagen A, Sturdee DW. Testosterone treatment of HSDD in naturally menopausal women: The ADORE study. Climacteric 2010;13:121-131.
15. Somboonporn W, Davis S, Seif MW, Bell R. Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev 2005;(4):CD004509.
16. Miller KK, Biller BMK, Beauregard C, Lipman JG, Jones J, Schoenfeld D, Sherman JC, Swearingen B, Loeffler J, Klibanski A. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: A randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2006;91:1683-1690.
17. Davison SL, Davis SR. Androgenic hormones and aging-The link with female sexual function. Horm Behav 2011;59:745-753.
18. Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294:91-96.
19. Basson R, Brotto LA, Petkau AJ, Labrie F. Role of androgens in women's sexual dysfunction. Menopause 2010;17:962-971.
20. Stanczyk FZ. Measurement of androgens in women. Semin Reprod Med 2006;24:78-85.
21. Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 2006;99:182-188.
22. Alder J, Zanetti R, Wight E, Urech C, Fink N, Bitzer J. Sexual dysfunction after premenopausal stage I and II breast cancer: Do androgens play a role? J Sex Med 2008;5:1898-1906.
23. Zimmerman Y, Eijkemans MJC, Coelingh Bennink HJT, Blankenstein MA, Fauser BCJM. The effect of combined oral contraception on testosterone levels in healthy women: A systematic review and meta-analysis. Hum Reprod Update 2014;20:76-105.
24. Casson PR, Elkind-Hirsch KE, Buster JE, Hornsby PJ, Carson SA, Snabes MC. Effect of postmenopausal estrogen replacement on circulating androgens. Obstet Gynecol 1997;90:995-998.
25. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
26. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): Cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005;31:1-20.
27. Gerstenberger EP, Rosen RC, Brewer JV, Meston CM, Brotto LA, Wiegel M, Sand M. Sexual desire and the female sexual function index (FSFI): A sexual desire cutpoint for clinical interpretation of the FSFI in women with and without hypoactive sexual desire disorder. J Sex Med 2010;7:3096-3103.
28. Petersen CD, Giraldi A, Lundvall L, Kristensen E. Botulinum toxin type A-a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study. J Sex Med 2009;6:2523-2537.
29. Bartsch W. Interrelationships between sex hormone-binding globulin and testosterone, 5 alpha-dihydrotestosterone and oestradiol-17 beta in blood of normal men. Maturitas 1980;2:109-118.
30. Santoro N, Torrens J, Crawford S, Allsworth JE, Finkelstein JS, Gold EB, Korenman S, Lasley WL, Luborsky JL, McConnell D, Sowers MF, Weiss G. Correlates of circulating androgens in mid-life women: The study of women's health across the nation. J Clin Endocrinol Metab 2005;90:4836-4845.
31. Burger HG. Androgen production in women. Fertil Steril 2002;77(Suppl 4):S3-5.
32. Davis SR, Goldstat R, Papalia M-A, Shah S, Kulkarni J, Donath S, Bell RJ. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause 2006;13:37-45.
33. Mushayandebvu T, Castracane VD, Gimpel T, Adel T, Santoro N. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fertil Steril 1996;65:721-723.
34. Salonia A, Pontillo M, Nappi RE, Zanni G, Fabbri F, Scavini M, Daverio R, Gallina A, Rigatti P, Bosi E, Bonini PA, Montorsi F. Menstrual cycle-related changes in circulating androgens in healthy women with self-reported normal sexual function. J Sex Med 2008;5:854-863.
35. Caruso S, Agnello C, Malandrino C, Lo Presti L, Cicero C, Cianci S. Do hormones influence women's sex? Sexual activity over the menstrual cycle. J Sex Med 2014;11:211-221.
36. Stuckey BGA. Female sexual function and dysfunction in the reproductive years: The influence of endogenous and exogenous sex hormones. J Sex Med 2008;5:2282-2290.
37. Giagulli VA, Giorgino R, Vermeulen A. Origin and significance of plasma androsterone glucuronide levels: A parameter of adrenal androgen secretion and hepatic 5 alpha-reductase activity. J Clin Endocrinol Metab 1993;76:918-923.
38. Horton R, Hawks D, Lobo R. 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism. J Clin Invest 1982;69:1203-1206.
39. Elaut E, Buysse A, De Sutter P, De Cuypere G, Gerris J, Deschepper E, T'Sjoen G. Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users. Contraception 2012;85:470-479.
40. Elaut E, Bogaert V, De Cuypere G, Weyers S, Gijs L, Kaufman J-M, T'Sjoen G. Contribution of androgen receptor sensitivity to the relation between testosterone and sexual desire: An exploration in male-to-female transsexuals. J Endocrinol Invest 2010;33:37-41.
41. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: Changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005;90:3847-3853.